Search All UT System Experts

A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group study (E1501)

Gregory A. Masters, Sigui Li, Afshin Dowlati, Stefan Madajewicz, Corey Langer, Joan Schiller, David Johnson

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group study (E1501)'. Together they form a unique fingerprint.

Medicine & Life Sciences